23andme anne wojcicki

News

Anne Wojcicki to buy back 23andMe and its data

Anne Wojcicki's bid to buy back 23andMe may not end a legal fight over DNA customer data

Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.

· 1h

Anne Wojcicki on genetic privacy, data security and the money behind her bid for 23andMe

MedTech Dive · 3h

Anne Wojcicki wins bid to buy back 23andMe for $305M

5hon MSN

Regeneron is said to have declined a higher bid for 23andMe after Wojcicki's offer

Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a ...

4hon MSN

Anne Wojcicki's bid to buy back 23andMe may not end legal fight over DNA customer data

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

Anne Wojcicki to buy back 23andMe and its data

Trending now